Pharmadrug Inc.
PHRX
CNSX
| 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | |
|---|---|---|---|---|---|
| Revenue | -- | -- | -- | -- | -- |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | -- | -- | -- | -- | -- |
| Cost of Revenue | -- | -- | -- | -- | -- |
| Gross Profit | -- | -- | -- | -- | -- |
| SG&A Expenses | 37.60K | 47.50K | 295.40K | 773.90K | 826.20K |
| Depreciation & Amortization | 36.10K | 36.20K | 36.70K | 47.00K | 37.80K |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 148.20K | 135.40K | 432.00K | 892.60K | 988.80K |
| Operating Income | -148.20K | -135.40K | -432.00K | -892.60K | -988.80K |
| Income Before Tax | -280.60K | -324.50K | -644.30K | -10.47M | -10.56M |
| Income Tax Expenses | -- | -- | -- | -742.60K | -742.60K |
| Earnings from Continuing Operations | -0.28 | -0.32 | -0.64 | -9.73 | -9.82 |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | 77.70K | 78.40K | 99.30K | 87.10K | 87.10K |
| Net Income | -203.00K | -246.30K | -545.10K | -9.64M | -9.73M |
| EBIT | -148.20K | -135.40K | -432.00K | -892.60K | -988.80K |
| EBITDA | -112.10K | -99.20K | -395.30K | -860.00K | -963.20K |
| EPS Basic | 0.00 | 0.00 | -0.01 | -0.13 | -0.13 |
| Normalized Basic EPS | 0.00 | 0.00 | 0.00 | -0.01 | -0.01 |
| EPS Diluted | 0.00 | 0.00 | -0.01 | -0.13 | -0.13 |
| Normalized Diluted EPS | 0.00 | 0.00 | 0.00 | -0.01 | -0.01 |
| Average Basic Shares Outstanding | 423.44M | 415.59M | 402.74M | 372.98M | 319.64M |
| Average Diluted Shares Outstanding | 423.44M | 415.59M | 402.74M | 372.98M | 319.64M |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |